A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

PHASE3CompletedINTERVENTIONAL
Enrollment

962

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

September 26, 2025

Study Completion Date

September 26, 2025

Conditions
Type 2 Diabetes
Interventions
DRUG

Orforglipron

Administered orally

DRUG

Dapagliflozin

Administered orally

Trial Locations (74)

407

Taichung Veterans General Hospital, Taichung

704

National Cheng Kung University Hospital, Tainan City

807

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

10002

National Taiwan University Hospital, Taipei

11217

Taipei Veterans General Hospital, Taipei

14050

ProcliniQ Investigación Clínica SA de CV, Mexico City

20230

Fundación Cardiovascular de Aguascalientes A.C., Aguascalientes

21109

Diabetes Zentrum Wilhelmsburg, Hamburg

23758

RED-Institut GmbH, Oldenburg in Holstein

24352

Fu Jen Catholic University Hospital, New Taipei City

27103

Accellacare - Winston-Salem, Winston-Salem

29464

Accellacare - Mt Pleasant, Mt. Pleasant

30281

Institute of Endocrinology Diabetes, Health & Hormone, Stockbridge

34000

Lahoja. Asociacion Para La Investigacion Y La Farmacovigilancia, Durango

37760

Accellacare, US Inc., d/b/a Accellacare of Knoxville, Jefferson City

42000

Grupo Ollin Care, Pachuca

44600

Instituto Jalisciense de Investigacion en Diabetes y Obesidad, Guadalajara

44869

Diabetes- und Stoffwechselpraxis Bochum, Bochum

45136

InnoDiab Forschung Gmbh, Essen

45355

Medizentrum Essen Borbeck, Essen

48145

Institut für Diabetesforschung GmbH Münster, Münster

49808

Diabetologische Schwerpunktpraxis Dr. Staudenmeyer & Dr. Schiwietz, Lingen

51069

Zentrum fur klinische Forschung - Köln, Cologne

59101

St. Vincent Healthcare, Billings

60148

Accellacare - DuPage, Lombard

62250

Instituto de Diabetes, Obesidad y Nutricion, Cuernavaca

64060

Cardiolink Clin Trials, Monterrey

64610

Clínica García Flores SC, Monterrey

66386

Zentrum für klinische Studien, Saint Ingbert

66450

Servicios Integrales Nova de Monterrey S.A. de C.V., San Nicolás de los Garza

66780

Praxis Dr. Veronika Wenzl-Bauer, Rehlingen

68167

CRS Clinical Research Services Mannheim, Mannheim

70072

Tandem Clinical Research, Marrero

73069

Alliance for Multispecialty Research, LLC, Norman

74137

Essential Medical Research, Tulsa

75230

Velocity Clinical Research, Dallas, Dallas

77040

Juno Research, Houston

78231

Consano Clinical Research, LLC, Shavano Park

80230

Centro Para El Desarrollo de La Medicina Y de Asistencia Medica Especializada S.C., Culiacán

81362

Kaohsiung Veterans General Hospital, Kaohsiung City

83301

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist

83440

Elite Clinical Trials, Rexburg

87102

Albuquerque Clinical Trials, Inc., Albuquerque

90720

Collaborative Neuroscience Research, LLC, Los Alamitos

90815

Ark Clinical Research, Long Beach

91193

Consultorio de Medicina Especilizada del Sector Privado, Xalapa

Hospital Angeles Xalapa, Xalapa

91304

Alliance Research Institute - Canoga Park, Canoga Park

92706

Wolverine Clinical Trials, Santa Ana

150001

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

210006

Nanjing First Hospital, Nanjing

210011

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

212000

Affiliated Hospital of Jiangsu University, Zhenjiang

215006

The First Affiliated Hospital of Soochow University, Suzhou

230011

The Second People's Hospital of Hefei, Hefei

250013

Jinan Central Hospital, Jinan

325000

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

450014

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou

473007

The First Affiliated Hospital of Nanyang Medical College, Nanyang

650032

First Affiliated Hospital of Kunming Medical University, Kunming

06517

CMR of Greater New Haven, LLC, Hamden

Unknown

Shanghai Sixth People's Hospital, Shanghai

06100

Cryptex Investigación Clínica S.A. de C.V., Cuauhtémoc, Ciudad de México

85-231

NZOZ Centrum Medyczne KERmed, Bydgoszcz

31-261

Medyczne Centrum Diabetologiczno Endokrynologiczno Metaboliczne DIAB-ENDO-MET, Krakow

50-162

Centrum Badań Klinicznych Piotr Napora lekarze sp.p., Wroclaw

20-011

Clinical Best Solutions, Lublin

20-044

CenterMed Lublin NZOZ, Lublin

20-718

Ekamed, Lublin

26-600

"Centrum Medyczne Diabetika", Radom

15-351

Zdrowie Osteo-Medic, Bialystok

15-375

Specderm Poznanska, Bialystok

41-800

Samodzielny Publiczny Szpital Kliniczny nr 1 SUM, Zabrze

90-338

Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna, Lodz

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT06192108 - A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin | Biotech Hunter | Biotech Hunter